| detox | detoxification |
|---|---|
| DTX | detoxification |
| CPBA | Competitive Protein Binding Assay |
| AOO | anodal opening odor; atrial asynchronous (competitive, fixed-rate) [pacemaker] |
| CBPA | competitive protein-binding assay |
| C-ELISA | Competitive ELISA |
|---|---|
| cPCR | Competitive PCR |
| C-ELISA | Competitive enzyme-linked immunosorbent assay |
| CE | Competitive exclusion |
| cPCR | Competitive polymerase chain reaction |
| sorption detoxification | Elimination of toxic or biologically active substances from body fluids by interaction with a sorbent medium. The types of media include absorbents, adsorbents, ion-exchange materials, and complexing agents. Detoxification can be extracorporeal (haemodialysis, haemofiltration, haemoperfusion, plasmapheresis), or occur inside the body (enterosorption, peritoneal dialysis). (12 Dec 1998) |
|---|---|
| detoxification | Treatment designed to free an addict from his drug habit. (18 Nov 1997) |
| detoxification reaction | Reactions taking place generally in the liver or kidney in order to inactivate toxins, either by degradation or else by conjugation of residues to a hydrophilic moiety to promote excretion. (18 Nov 1997) |
| competitive antagonist | An antimetabolite. (05 Mar 2000) |
| competitive behaviour | The direct struggle between individuals for environmental necessities or for a common goal. (12 Dec 1998) |
| competitive bidding | Pricing statements presented by more than one party for the purpose of securing a contract. (12 Dec 1998) |
| competitive binding assay | General term for an assay in which a binder competes for labelled versus unlabelled ligand; following separation of free and bound ligand, the ligand (the analyte assayed) is quantitated by relating bound and unbound ratios to known standards. See: enzyme-linked immunosorbent assay, radioreceptor assay, immunoassay, enzyme-multiplied immunoassay technique, radioimmunoassay. Synonym: displacement analysis, saturation analysis. (05 Mar 2000) |
| competitive inhibition | <chemistry> Inhibitor that occupies the active site of an enzyme or the binding site of a receptor and prevents the normal substrate or ligand from binding. at sufficiently high concentration of the normal ligand inhibition is lost: the Km is altered by the competitive inhibitor, but the Vmax remains the same. (05 Jan 1998) |
| competitive medical plans | Alternative health care delivery mechanisms, such as preferred provider organizations or other health insurance services or prepaid plans (other than health maintenance organizations), that meet medicare qualifications for a risk-sharing contract. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|